Skip to main content

Table 2 Available epinephrine autoinjectors in Canada with current product monograph at time of publication and CSACI recommendations

From: CSACI position statement: transition recommendations on existing epinephrine autoinjectors

Brand Available doses (mg) Product monograph recommendations CSACI recommendations
EpiPen® 0.30 For those who weigh ≥ 30 kg EpiPen® is recommended for those ≥ 25 kg
EpiPen Jr® 0.15 For those who weigh between 15 and 30 kg For those < 25 kg, the EpiPen Jr® is recommended
Allerject® 0.30 For those who weigh ≥ 30 kg For those ≥ 25 kg, the Allerject® 0.30 mg is recommended
Allerject® 0.15 For those who weigh 15–30 kg For those < 25 kg, the Allerject® 0.15 mg is recommended
Emerade™ 0.50 Adult: > 60 kg: 0.3 to 0.5 mg depending on clinical judgement For those ≥ 45 kg, the Emerade™ 0.5 mg is recommended
Emerade™ 0.30 Pediatric: Children > 30 kg: 0.3 mg For those ≥ 25 kg to < 45 kg, the Emerade™ 0.30 mg is recommended
Adolescent > 30 kg: The dosage recommendations for adult patients should be followed
Adult: < 60 kg: 0.3 mg